Dr Robert Foldes

Guest Contributor
September 1, 2000

Dr Robert Foldes has been appointed president and CEO of Cytochroma Inc, an early-stage developer of drug compounds based on cytochrome P450 enzymzes. Foldes joins the Kingston ON-based firm after a stint at Toronto's Hospital for Sick Children, where he served as director of research business development and established its intellectual property and commercialization development office. Prior to that, he spent seven years at Allelix Biopharmaceuticals Inc. Foldes received his BSc from the Univ of Toronto, a PhD in pharmacology at the Univ of Nebraska Medical Centre and an MBA at York Univ. At Cytochroma, Foldes will develop new business opportunities and commercialize its proprietary technology....


Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.